Immediate Impact
6 from Science/Nature 71 standout
Citing Papers
Triple hormone receptor agonist retatrutide for metabolic dysfunction-associated steatotic liver disease: a randomized phase 2a trial
2024 Standout
Tirzepatide for Obesity Treatment and Diabetes Prevention
2024 Standout
Works of Libbey S. O′Farrell being referenced
LY3437943, a novel triple glucagon, GIP, and GLP-1 receptor agonist for glycemic control and weight loss: From discovery to clinical proof of concept
2022 Standout
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Libbey S. O′Farrell | 246 | 140 | 271 | 243 | 16 | 600 | |
| Michael Lund | 170 | 222 | 298 | 344 | 27 | 665 | |
| Nina Perwitz | 198 | 126 | 146 | 396 | 17 | 693 | |
| Stephan Sachs | 232 | 73 | 213 | 257 | 15 | 684 | |
| Holly E. Bates | 156 | 60 | 198 | 182 | 14 | 531 | |
| H. L. Lickley | 176 | 47 | 237 | 328 | 30 | 661 | |
| Shu-Chen Lu | 404 | 94 | 221 | 141 | 12 | 665 | |
| Jun Namkung | 231 | 44 | 146 | 291 | 21 | 690 | |
| Todd M. Suter | 251 | 118 | 253 | 276 | 12 | 706 | |
| Ann-Marie Richard | 251 | 59 | 120 | 238 | 11 | 522 | |
| Satyesh K. Sinha | 243 | 125 | 149 | 127 | 23 | 691 |
All Works
Login with ORCID to disown or claim papers
Loading papers...